TUESDAY, May 20, 2025 (HealthDay News) — Women who don’t brush and floss frequently are more likely to suffer from migraines and fibromyalgia, a new study says. Women with the worst oral health have a 60% higher risk of moderate to severe body pain, and a 49% greater risk ofContinue Reading
FRIDAY, May 9, 2025 (HealthDay News) — Women with common autoimmune inflammatory diseases are more likely than men to die from heart disease, a new study says. Women with rheumatoid arthritis, lupus or systemic sclerosis have a 50% higher heart disease-related death rate than men, researchers reported May 5 inContinue Reading
THURSDAY, May 8, 2025 (HealthDay News) — Fast food and ready-made packaged eats could be doing slow damage to people’s brains. Ultra-processed foods like breakfast cereals, soft drinks, hot dogs and ketchup appear to increase a person’s risk of developing Parkinson’s disease, a new study says. People who ate aboutContinue Reading
THURSDAY, May 1, 2025 (HealthDay News) — A class of drugs used to treat epilepsy, nerve pain and anxiety do not appear to increase a person’s risk of self-harm, a major new study says. Gabapentinoids – which include gabapentin and pregabalin – have been associated with an increased risk ofContinue Reading
THURSDAY, April 17, 2025 (HealthDay News) — Common medications like aspirin, ibuprofen, statins and beta blockers appear to slow the progress of Parkinson’s disease, a new study says. Parkinson’s symptoms took nearly a decade longer to crop up in patients taking these drugs to treat pain, high blood pressure, diabetesContinue Reading
MONDAY, March 17, 2025 (HealthDay News) — The blues and the jitters are very common among people battling chronic pain, a new evidence review says. About 40% of adults with chronic pain have symptoms of depression or anxiety, researchers report in JAMA Network Open. Women, younger adults and people sufferingContinue Reading
FRIDAY, March 7, 2025 (HealthDay News) — The number of people with Parkinson’s disease will more than double by 2050, driven by the aging of the global population, a new study suggests. In all, 25.2 million people will be living with Parkinson’s by 2050, researchers project in The BMJ. “AnContinue Reading
MONDAY, March 3, 2025 — A patient with multiple autoimmune diseases can remember the exact moment a doctor tore their heart out. “One doctor told me I was making myself feel pain, and I still can’t forget those words,” the patient remembered. “Telling me I’m doing it to myself hasContinue Reading
WEDNESDAY, Feb. 19, 2025 (HealthDay News) — Lupus can do irreversible harm to a person’s organs, damaging the lungs, kidneys, heart, liver and other vital organs through inflammation. But a newer lupus drug appears to protect patients from much of this organ damage, a new study suggests. Anifrolumab (brand nameContinue Reading
Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced diseaseContinue Reading
WEDNESDAY, Feb. 5, 2025 (HealthDay News) — Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson’s disease have taken an hit. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easingContinue Reading
WEDNESDAY, Jan. 15, 2024 (HealthDay News) — People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the arteries. Lupus patients with skin symptoms are 72% more likely to develop atherosclerotic heart disease, in which arteries become clogged and less flexible, researchers reported inContinue Reading
THURSDAY, Jan. 9, 2025 (HealthDay News) — A pain-relieving medication might be safer for seniors than first thought. A new study published Jan. 7 in the Annals of Internal Medicine says Gabapentin is widely used to help treat chronic pain and nerve pain, particularly as an alternative to opioid painkillers.Continue Reading
THURSDAY, Dec. 19, 2024 (HealthDay News) — Parkinson’s is a relentless disease for which few treatments, and no real cure, exists. Now, researchers say they are on the trail of a potential new therapy for the disabling neurological illness. It’s early research, still in the animal-testing stage, as explained byContinue Reading